RESUMO
BACKGROUND: It is generally acknowledged that the posterior ethmoidal cells drain under the superior nasal turbinate (SorNT) or, rarely, under the supreme nasal turbinate (SmeNT), and the sphenoid ostium (SO) opens to the sphenoethmoidal recess. However, detailed relations between these structures are variable, complex and still not clear. There is no reliable data on the prevalence of SmeNT and drainage of the posterior ethmoidal cells under this structure. The aim of this study was to re-evaluate the anatomy of the aforementioned region. MATERIALS AND METHODS: Multiplanar and three-dimensional reconstruction analysis of 100 thin slice paranasal sinus computed tomography scans. RESULTS: SmeNT was identified in 77 subjects (136 sides). It formed the ostium to the posterior ethmoidal cell adjacent to the skull base or orbit in 58 subjects (91 sides). This cell drained independently from the remaining posterior ethmoidal cells. The sphenoethmoidal (Onodi) cell drained to supreme meatus in 41 subjects (54 sides), and to superior meatus in 37 subjects (49 sides). SO was always located medial to the posteroinferior attachment of SmeNT, or SorNT (in absence of SmeNT). CONCLUSIONS: Patients with divergent drainage of the posterior ethmoids (with posterior ethmoidal cell draining to the supreme meatus) may require more extensive surgery to avoid persistence or recurrence of inflammatory disease. SmeNT is more common than thought, but due to its posterior and superior location to SorNT, it is rarely seen intraoperatively. If SmeNT is present, SO is always located medial to its posteroinferior attachment. (Folia Morphol 2018; 77, 1: 110-115).
Assuntos
Seio Etmoidal/diagnóstico por imagem , Órbita/diagnóstico por imagem , Seio Esfenoidal/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Conchas Nasais/diagnóstico por imagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Drenagem , Seio Etmoidal/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Órbita/cirurgia , Conchas Nasais/cirurgiaRESUMO
BACKGROUND: Over the last decade, there has been an increase in the use of the endonasal endoscopic approach for removing frontal sinus and frontal recess osteomas. This study aimed to describe an endoscopic endonasal treatment of osteomas without the need for an external approach. MATERIALS AND METHODS: We performed a retrospective analysis of patients that had received operations over a 5-year period in a single center. RESULTS: Twenty-nine patients underwent endoscopic osteoma resections. The osteomas were graded according to the Chiu and Kennedy grading system: 12 had type I, 2 had type II, 13 had type III, and 2 had type IV osteomas. The most common indication for surgery was frontal pain. Removal of the osteoma was incomplete in three patients. Of these, one underwent successful transnasal reoperation, and the other two had tumors that extended near the mid-orbital line and were attached to the orbital roof. Based on an 11-point scale (0--no pain, 10--maximum pain), the mean pain intensity decreased from 7.5 before surgery to 3.3 (p < 0.005) after surgery for patients that underwent surgery due to frontal pain. CONCLUSION: We found that exclusively transnasal endoscopic resections of frontal sinus osteomas were safe. However, this approach can be inadequate under some conditions. An auxiliary external approach may be required when the frontal ostium is narrow and/or when tumors are extensively attached to the orbital roof, and grow close to the midorbital point.
Assuntos
Neoplasias Ósseas/cirurgia , Endoscopia/métodos , Osso Frontal , Seio Frontal , Osteoma/cirurgia , Neoplasias dos Seios Paranasais/cirurgia , Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nariz , Estudos Retrospectivos , Adulto JovemRESUMO
BACKGROUND: Specific immunotherapy (SIT) is the only treatment producing lasting clinical improvement in patients with allergy. We investigated the long-term effect of SIT treatment on the expression of chemokines: eotaxin, RANTES (regulated upon activation, normal T cell expressed and secreted) and thymus and activation-regulated chemokine (TARC), and their receptors CCR3 and CCR4 in biopsies of nasal mucosa from birch-allergic individuals. METHODS: Sixteen patients who completed a 3-year treatment programme 3-5 years ago, and 12 untreated, matched controls were included in the study. Patients recorded symptoms and use of rescue medication before and during the pollen season. Nasal mucosa samples obtained before and during the season were stained for eosinophil and mast cell markers and for eotaxin, RANTES, TARC, CCR3 and CCR4. RESULTS: During the pollen season, rhinoconjunctivitis symptoms increased in both SIT and control groups (P=0.001 and 0.002, respectively). However, SIT patients had 37% fewer symptoms than controls. Medication use increased in both groups (P=0.002) during the season but the SIT group used 28% less than the controls (P=0.02). The number of eosinophils in the nasal mucosa increased in the control group (P=0.01) and the difference between the groups was significant during the season (P=0.01). No seasonal increase in the numbers of mast cells was seen, but during the pollen season, more (P=0.02) AA(+) cells were found in the controls than in the SIT group. The number of eotaxin(+) and RANTES(+) cells increased in the control group (P=0.01 and 0.03, respectively) and the difference between groups during the season was significant (P=0.01 and 0.01, respectively). The TARC(+) cell numbers were lower in the SIT group during the season (P=0.003). The CCR3(+) cells increased only in the control group during the pollen season and remained unchanged in SIT patients, while CCR4(+) cell numbers increased in both the control (P=0.03) and SIT (P=0.02) groups. CONCLUSION: This study confirmed that decreased numbers of eosinophils in the nasal mucosa is a long-lasting effect of birch SIT. SIT also prevented seasonal rises in the number of cells expressing the chemokines eotaxin and RANTES.
Assuntos
Alérgenos/imunologia , Betula/imunologia , Quimiocinas/análise , Dessensibilização Imunológica , Eosinófilos/imunologia , Hipersensibilidade/imunologia , Mucosa Nasal/imunologia , Adulto , Eosinófilos/metabolismo , Feminino , Seguimentos , Humanos , Hipersensibilidade/terapia , Masculino , Pessoa de Meia-Idade , Mucosa Nasal/metabolismo , Receptores de Quimiocinas/análise , Receptores de Quimiocinas/imunologiaRESUMO
BACKGROUND: The effect of bilateral nasal provocation on nasal mucosa measured with the use of acoustic rhinometry (AR) can be assessed for both nasal passages or for the side responding with greater congestion. Assessment of changes in nasal congestion during the nasal provocation test (NPT) can be affected by the nasal cycle (NC). The aim of this study was to find out the most accurate method to evaluate changes observed during bilateral nasal provocation. METHODS: Cross-sectional areas (CSA) at the level of inferior nasal turbinate (CSA-2) were recorded by AR in 26 volunteers with allergic rhinitis during the NC for 5-7 h and subsequently during NPT. The risk of spontaneous total and unilateral CSA-2 decrease was established. Sensitivity of the NPT assessment for the total CSA-2 and for the side responding with greater congestion was evaluated at chosen thresholds. These thresholds were selected in a way that the risk levels of spontaneous decrease of unilateral and total CSA-2 were equal. RESULTS: The assessment of the total CSA-2 was found to be more sensitive than the assessment of the side responding with greater congestion. The highest sensitivity and specificity of the test was achieved by using a combination of both assessments. Optimum thresholds of the CSA-2 decrease for assessment at 15 min after provocation, with this method, were 27% and 40% for the side responding with greater congestion and for the total CSA-2, respectively. CONCLUSIONS: Recognition of the risk of spontaneous unilateral and total CSA-2 decreases enables introduction of combined assessment of bilateral NPT. This assessment seems to be the most accurate method for evaluation of the test results.